US FDA grants full approval to AbbVie's ovarian cancer therapy
Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or walls of the abdomen, and have received one to three prior lines of treatment, according to the FDA.
Mar 25, 2024 04:59
ಜಾಹೀರಾತಿಗಾಗಿ ಸಂಪರ್ಕಿಸಿ 6362546216
Elahere was approved for adult patients with a type of cancer which affects the ovaries, fallopian tube, or walls of the abdomen, and have received one to three prior lines of treatment, according to the FDA.
